The Shanghai Municipal Bureau of Quality and Technical Supervision has announced that a cancer causing aromatic amine dye has been found in school uniforms manufactured in July last year by the Ouxia garment company. The eastern Chinese ...
Tags: Shanghai Authorities, aromatic amine dye, school uniforms
Dako, an Agilent Technologies Company, has launched instant quality in situ hybridization (IQISH) technology in the US, to lessen cancer evaluation turnaround time. IQISH technology, based on Dako's fast IQISH hybridization buffer ...
Tags: IQISH technology, cancer evaluation, cancer treatments
Biopharmaceutical and diagnostics company OPKO Health has acquired Brazilian pharmaceutical company Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos. The acquisition is expected to expand OPKO's ...
Tags: OPKO Health, Silcon, Biopharmaceutical
U3 Pharma, an antibody targeted cancer drug development affiliate of Daiichi Sankyo, has signed a research collaboration deal with AbCheck. AbCheck's commercial multi antibody discovery platforms include AbSieve, which combines the ...
Denmark-based cancer diagnostics solutions manufacturer Dako announced that it has entered into collaboration agreement with Pfizer in the field of companion diagnostics. The agreement includes a legal framework for various collaboration ...
Tags: cancer diagnostics solutions, Dako, Pfizer
Aspen Dental will inaugurate a new dental facility in Gallatin, Tennessee, US, on 21 February 2013, to provide dental services ranging from dentures and preventive care to general dentistry and restoration. Located at Nashville Pike, the ...
Tags: Aspen Dental, dental facility, Gallatin
Sequenta has introduced a sequencing-based test for minimal residual disease (MRD) for leukemia and lymphoma. The ClonoSIGHT test utilizes the company's proprietary LymphoSIGHT technology, which works by sequencing DNA signatures that are ...
Tags: Sequenta, sequencing-based test, minimal residual disease
Virtual colonoscopy is more effective than traditional X-ray tests for barium enema and should be looked at as a treatment for patients with possible bowel cancer. Despite these findings, researchers funded by the National Institute for ...
Tags: CT Scans, Best Alternative, Colonoscopy
BioTek extends congratulations to Ms Tanis Godwin and the Centre for Translational Cancer Research (CTCR) at the University of Otago in Dunedin, New Zealand for winning a new Epoch™ Micro-Volume Spectrophotometer System. The giveaway ...
Tags: BioTek, Ms Tanis Godwin, CTCR
Watson-Marlow Pumps Group is unveiling a new range of 400RXMD panel-mount pumps designed specifically to meet the demands from medical device specialists serving the surgical ablation market. Unique performance and robust modern design ...
Tags: New Generation Pumps, Medical Applications, Watson-Marlow Pumps Group
A world’s first education and research initiative announced on January 16th will see the UK spearhead a collaborative global search for more ethical, human-relevant alternatives to animal testing. To be led by The Dr Hadwen Trust ...
Tags: Animal Test Alternatives, animal testing, cancer research
TA Instruments has presented the Distinguished Young Rheologist Award to two scientists: Dr. Anson W. K. Ma, of the University of Connecticut, and Dr. Ali Mohraz, of the University of California, Irvine. The Award cited Dr. Ma’s ...
Tags: TA Instruments, Award, Instruments
Leading oncology company Incanthera has launched a partnership with global investment group Technomark Life Sciences. The two businesses will work together to prepare ICT2588 - Incanthera’s revolutionary treatment for solid tumours ...
Tags: Life Sciences, clinical trials, medical
Acceleron Pharma has announced that the Gynecologic Oncology Group (GOG) has sponsored its phase 2 study of dalantercept. Patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer are taking part in the ...
Domain Therapeutics SA announced today that Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting ...
Tags: Domain Therapeutics SA, chemical, drugs